Two Evogene Directors Resign Amid Activist Tender Offer Escalation
EVGN sits 43% above its 52-week low of $0.37.
Summary
Evogene disclosed that directors Yoshinori Oikawa and Yael Margolin resigned on September 9, 2026, while the company is in discussions with activist shareholders who have formally noticed a special tender offer.
Key Events · Executive and Board Changes · EVGN
-
Two Directors Resign
Yoshinori Oikawa and Yael Margolin each resigned from the board on September 9, 2026. Neither cited any disagreement with company operations, policies, or practices.
-
Activist Tender Offer Notice
On September 8, 2026, dissident shareholders L.I.A. Pure Capital Ltd. and Invest Pro Shukai Hon Ltd. served formal notice of intent to launch a special tender offer under Section 328 of the Israeli Companies Law.
-
Voting Results Disputed
The dissident shareholders have asserted claims concerning the voting results of the September 4, 2026 annual general meeting, which the company published in a prior 6-K.
-
Settlement Discussions Underway
Evogene is currently conducting discussions with the dissident shareholders to resolve the voting result claims and the tender offer matter.
Analysis · EVGN · Industrial Applications And Services
Two board members resigned on September 9, 2026, just days after dissident shareholders formally notified Evogene of their intent to launch a special tender offer under Israeli law. The resignations come amid an ongoing proxy battle that has already seen the activist group build a stake above 17% and reject a settlement offer. Losing two directors simultaneously weakens the incumbent board's position and may signal internal instability or pressure from the activist campaign. The company says neither resignation involved a disagreement over operations, policies, or practices, but the timing is notable given the September 4 annual meeting and the September 8 tender offer notice.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 37.1% of the 974 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.64%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EVGN was trading at $0.53 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8.3M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.